Quantum M&A Premiums

Quantum acquisitions cannot be assessed through ordinary revenue multiples alone. In a sector where many companies remain early-stage, loss-making or only partially commercialised, strategic value often lies in assets that do not yet appear fully in financial statements: scarce scientific teams, defensible intellectual property, roadmap acceleration, trusted manufacturing access, secure communications capabilities, government-facing credibility and control of critical components. The central problem is therefore not whether quantum companies are “expensive” by conventional measures, but what a strategic buyer is actually purchasing when it acquires a company, a team, a patent portfolio, a component supplier or a platform capability.